California Statutes
§ 4127.8. — 4127.8. (Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3.)
California·Code BPC Business and Professions Code - BPC·Div. 2. DIVISION 2. HEALING ARTS·Ch. 9. CHAPTER 9. Pharmacy·Art. 7.5. ARTICLE 7.5. Sterile Drug Products
(a)A pharmacy licensed pursuant to Section 4127.1 or 4127.2 that issues a recall notice regarding a sterile compounded drug shall, in addition to any other duties, contact the recipient pharmacy, prescriber, or patient of the recalled drug and the board as soon as possible within 12 hours of the recall notice if both of the following apply:
(1)Use of or exposure to the recalled drug may cause serious adverse health consequences or death.
(2)The recalled drug was dispensed, or is intended for use, in this state.
(b)A recall notice issued pursuant to subdivision (a) shall be made as follows:
(1)If the recalled drug was dispensed directly to the patient, the notice shall be made to the patient.
(2)If the recalled drug was dispensed directly to the prescriber, the notice shall be made to
Free access — add to your briefcase to read the full text and ask questions with AI
California § 4127.8. (4127.8. (Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3.)) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Legislative History
Added by renumbering Section 4127.9 by Stats. 2017, Ch. 649, Sec. 3. (SB 510) Effective January 1, 2018.